A computational model to predict the immune system activation by citrus-derived vaccine adjuvants

Bioinformatics

Volumn 32, Issue 17, 2016, Pages 2672-2680

  Pappalardo, Francesco ^a,c   Fichera, Epifanio ^b   Paparone, Nicoletta ^c   Lombardo, Alessandro ^c   Pennisi, Marzio ^a   Russo, Giulia ^a   Leotta, Marco ^a   Pedretti, Alessandro ^d   De Fiore, Francesco ^e   Motta, Santo ^a  

^a UNIVERSITY OF CATANIA   (Italy)

^b Etna Biotech SRL   (Italy)

^c Parco Scientifico e Tecnologico della Sicilia   (Italy)

^d UNIVERSITY OF MILAN   (Italy)

^e Softeco Sismat   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIGEN; IMMUNOLOGICAL ADJUVANT; INFLUENZA VACCINE;

AGED; BIOLOGICAL MODEL; CITRUS; FORECASTING; HUMAN; IMMUNE SYSTEM; IMMUNOCOMPROMISED PATIENT; NEWBORN;

ADJUVANTS, IMMUNOLOGIC; AGED; ANTIGENS; CITRUS; FORECASTING; HUMANS; IMMUNE SYSTEM; IMMUNOCOMPROMISED HOST; INFANT, NEWBORN; INFLUENZA VACCINES; PATIENT-SPECIFIC MODELING;

EID: 84990936363     PISSN: 13674803     EISSN: 14602059     Source Type: Journal    
DOI: 10.1093/bioinformatics/btw293     Document Type: Article

References (41)

1. Abbas, A.K. et al. (2014) Cellular and Molecular Immunology. 8th edn Elsevier, Philadelphia
2. Achdout, H. et al. (2003) Enhanced recognition of human NK receptors after influenza virus infection. J. Immunol., 171, 915-923
3. Achdout, H. et al. (2008) Influenza virus infection augments NK cell inhibition through reorganization of major histocompatibility complex class I proteins. J. Virol., 82, 8030-8037
4. Aldini, G. et al. (2011) An integrated high resolution mass spectrometric and informatics approach for the rapid identification of phenolics in plant extract. J. Chromatogr. A., 1218, 2856-2864
5. Allison, A.C. and Byars, N.E. (1991) Immunological adjuvants: desirable properties and side-effects. Mol. Immunol., 28, 279-284
6. Arita, M. and Suwa, K. (2008) Search extension transforms Wiki into a relational system: A case for flavonoid metabolite database. BioData Min., 1, 1-7
7. Baccam, P. et al. (2006) Kinetics of Influenza A virus infection in humans. J. Virol., 80, 7590-7599
8. Brubaker, S.W. et al. (2015) Innate immune pattern recognition: a cell biological perspective. Ann. Rev. Immunol., 33, 257-290
9. Bolton, E. et al. (2008) PubChem: integrated platform of small molecules and biological activities. Ann. Rep. Comput. Chem., 12, 217-241
10. Bouic, P.J. (2001) The role of phytosterols and phytosterolins in immune modulation: a review of the past 10 years. Curr. Opin. Clin. Nutr. Metab. Care, 4, 471-475
11. Bungener, L.B. et al. (2002) Virosome-mediated delivery of protein antigens to dendritic cells. Vaccine, 20, 2287-2295
12. Carrat, F. et al. (2008) Time lines of infection and disease in human Influenza: a review of volunteer challenge studies. Am. J. Epidemiol., 167, 775-785
13. Castiglione, F. et al. (2007) Optimization of HAART with genetic algorithms and agent based models of HIV infection. Bioinformatics, 23, 3350-3355
14. Celada, F. and Seiden, P.E. (1996) Affinity maturation and hypermutation in a simulation of the humoral immune response. Eur. J. Immunol., 26, 1350
15. Doherty, P.C. et al. (2006) Influenza and the challenge for immunology. Nat. Immunol., 7, 449-455
16. Farmer, J.D. et al. (1986) The immune system, adaption, and machine learning. Phisica D, 22, 187-204
17. Gamal, A. and Abdelaziz, S.A.A. (2013) Differential effect of hesperidin on Th1, Th2, Th17, and proin-flammatory cytokines production from splenocyte of Schistosoma mansoni-infected mice. Centr. Eur. J. Immunol., 38, 29-36
18. Garg, A. et al. (2001) Chemistry and pharmacology of the citrus bioflavonoid hesperidin. Phytother. Res., 15, 655-669
19. Glenny, A.T. et al. (1926) Immunological notes: XVII-XXIV. J. Pathol. Bacteriol., 29, 31-40
20. Gonzalez-Quintela, A. et al. (2008) Serum levels of immunoglobulins (IgG, IgA, IgM) in a general adult population and their relationship with alcohol consumption, smoking and common metabolic abnormalities. Clin. Exp. Immunol., 15, 42-50
21. Grayson, M.H. and Holtzman, M.J. (2007) Emerging role of dendritic cells in respiratory viral infection. J. Mol. Med., 85, 1057-1068
22. Hong-Xiang, S. et al. (2009) Advances in saponin-based adjuvants. Advances in saponin-based adjuvants. Vaccine, 27, 1787-179
23. Huckriede, A. et al. (2005) The virosome concept for influenza vaccines. Vaccine, Suppl 1, S26-S38
24. Korb, O. et al. (2009) Empirical scoring functions for advanced protein-ligand docking with PLANTS. J. Chem. Inf. Model., 49, 84-96
25. Lamb, R.A. and Krug, R.M. (2001) Orthomyxoviridae: the viruses and their replication, In: Knipe, D.M., Howley, P.M. (eds) Fields Virology Fourth Edition. Lippincott, Philadelphia, USA, pp. 1487-1531
26. MacKerell, A.D.J. (1998) All-atom empirical potential for molecular modeling and dynamics studies of proteins. J. Phys. Chem. B., 102, 3586-3616
27. Marrack, P. et al. (2009) Towards an understanding of the adjuvant action of aluminium. Nat. Rev. Immunol., 9, 287-293
28. Montomoli, E. et al. (2011) Current adjuvants and new perspectives in vaccine formulation. Expert Rev. Vacc., 10, 1053-1061
29. Motta, S. et al. (2005) Modelling vaccination schedules for a cancer immunoprevention vaccine. Immun. Res., 1, 5
30. Newby, C.M. et al. (2006) Influenza A virus infection of primary differentiated airway epithelial cell cultures derived from Syrian golden hamsters. Virology, 354, 80-90
31. Ohto, U. et al. (2012) Structural basis of species-specific endotoxin sensing by innate immune receptor TLR4/MD-2. Proc. Natl. Acad. Sci. USA, 109, 7421-7426
32. Palladini, A. et al. (2010) In silico modeling and in vivo efficacy of cancerpreventive vaccinations. Cancer Res., 70, 7755-7763
33. Pappalardo, F. et al. (2014) Induction of T cell memory by a dendritic cell vaccine: a computational model. Bioinformatics, 30, 1884-1891
34. Pedretti, A. et al. (2002) VEGA: a versatile program to convert, handle and visualize molecular structure on windows-based PCs. J. Mol. Graph., 21, 47-49
35. Pennisi, M. et al. (2015) Agent based modeling of the effects of potential treatments over the blood-brain barrier in multiple sclerosis. J. Immunol. Methods, 427, 6-12
36. Phillips, J.C. et al. (2005) Scalable molecular dynamics with NAMD. J. Comput. Chem., 26, 1781-1802
37. Stark, G.R. et al. (1998) How cells respond to interferons. Annu. Rev. Biochem., 67, 227-264
38. Thorne, B.C. et al. (2007) Combining experiments with multi-cell agentbased modeling to study biological tissue patterning. Brief. Bioinfo., 8, 245-257
39. Vajdy, M. (2011) Immunomodulatory properties of vitamins, flavonoids and plant oils and their potential as vaccine adjuvants and delivery systems. Expert Opin. Biol. Ther., 11, 1501-1513
40. Wang, X. et al. (2000) Influenza A virus NS1 protein prevents activation of NF-KB and induction of alpha/beta interferon. J. Virol., 74, 11566-11573
41. Weihrauch, J.L. and Gardner, J.M. (1978) Sterol content of foods of plant origin. J. Am. Diet Assoc., 73, 39-47